29Oct
Related Posts
04Nov
PlateletBio Completes $75.5M Series B Financing
PlateletBio, a preclinical-stage biotechnology company pioneering an entirely new platform of allogeneic cell therapies based on platelet biology, today announced... read more
16Dec
Researchers Genetically Program B Cells to Treat Genetic Disorder
A Seattle-based biotech company is conducting a trial using genetically programmed B cells to treat a genetic disorder called mucopolysaccharidosis... read more
15Oct
Wasabi continues Asian partner expansion, adds new regional leader
Wasabi Technologies has chosen Sunny Chua as its Southeast Asia country manager, with the remit of enabling partners and customers... read more
14Apr
Framingham company converts manufacturing for cleaner, disinfectant
DetraPel Inc., a Framingham-based cleantech manufacturer of protective coatings, recently converted their entire manufacturing operation to produce DetraPel ecoCleaner and... read more
08Oct
Blind nursing student awarded with eSight glasses to see
First-year nursing student Emma Van Dyk, who is legally blind, is one of five Canadian students awarded with a medical... read more
16Aug
Premama® Designates Today as National Moms Who Pump Day
Premama®, a Rhode Island startup and the first nationwide line of pill-free, natural prenatal supplements is announcing today as "National... read more
27Apr
Ohio teen can see thanks to revolutionary technology
Primo Averion takes in the sights outside of his home for the first time in a decade Thursday with the... read more
13Jun
Neuroprotection Drugs Market is Expected to Reach US$ 33,481.7 Million by 2027 with major key players
Rising usage of atypical antipsychotics, omega‐3 fatty acids, antidepressants, glutamateric neurotransmission modulators, erythropoietin, COX‐2 inhibitors and N‐acetylcysteine have anti‐apoptotic properties... read more
23May
Corbus Pharmaceuticals Adds Two Key Executives to Lead its Regulatory and CMC Operations
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to... read more
31May
District Ventures Capital Invests in Premama Wellness
District Ventures Capital (District Ventures) announced today it has closed an equity investment with Premama Wellness (Premama), producers of a... read more